Health Products

Jamp-Metformin Product Recall (2020-03-10)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

A. Jamp-Metformin 500 mg tablet   

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
X20385, X20386, X19224, X19225, X19226
Recalling Firm
JAMP Pharma Corporation
1310 Nobel Street
Boucherville
J4B 5H3
Quebec
CANADA
Marketing Authorization Holder
JAMP Pharma Corporation
1310 Nobel Street
Boucherville
J4B 5H3
Quebec
CANADA
B. Jamp-Metformin 850 mg tabletDIN 02380218tabletMetformin hydrochloride 850 mg
X20283, X20284, X20286, X20287, X20288, Y00225, Y00226, Y00227, Y00228, Y00229, Y00230, Y00231, Y00232, Y01573, Y01574, Y01575, Y01576, Y01577, Y01578, Y01579, Y01580
Recalling Firm
JAMP Pharma Corporation
1310 Nobel Street
Boucherville
J4B 5H3
Quebec
CANADA
Marketing Authorization Holder
JAMP Pharma Corporation
1310 Nobel Street
Boucherville
J4B 5H3
Quebec
CANADA
A. Jamp-Metformin 500 mg tabletDIN 02380196tabletMetformin hydrochloride 500 mg

Introduction

A. Jamp-Metformin 500 mg tablet  

B. Jamp-Metformin 850 mg tablet

Reason

Affected lots may contain N-nitrosodimethylamine (NDMA) above the interim acceptable concentration limit.

Depth of distribution

Retailers

For more information

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime